Michael J. McGinley, Presi, Biologic. & Pharm at HESKA CORP (HSKA), sold 14,851 shares at $88.19 ($1.3M) on 2017-11-28, disclosed to the SEC on 2017-11-29.
Seasonal sale ($1.3M) by Presi, Biologic. & Pharm — this insider has traded HSKA in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.54 | 1 | $89 | 0.0% |
| 2 | $88.19 | 800 | $71K | 5.5% |
| 3 | $87.02 | 7,025 | $611K | 47.3% |
| 4 | $87.02 | 7,025 | $611K | 47.3% |
| Total | $87.08 avg | 14,851 | $1.3M | 100% |
| Filing → |
| HSKA | SELL | 2016-11-09 | $729K | — | Filing → |
| HSKA | SELL | 2016-05-10 | $219K | — | Filing → |
| HSKA | SELL | 2015-11-25 | $48K | — | Filing → |